These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20979082)

  • 1. Development of specific "drug-like property" rules for carboxylate-containing oral drug candidates.
    Böcker A; Bonneau PR; Hucke O; Jakalian A; Edwards PJ
    ChemMedChem; 2010 Dec; 5(12):2102-13. PubMed ID: 20979082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escape from flatland: increasing saturation as an approach to improving clinical success.
    Lovering F; Bikker J; Humblet C
    J Med Chem; 2009 Nov; 52(21):6752-6. PubMed ID: 19827778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing active template molecules by combining computational de novo design and human chemist's expertise.
    Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP
    J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of ALOGPS 2.1 to predict log D distribution coefficient for Pfizer proprietary compounds.
    Tetko IV; Poda GI
    J Med Chem; 2004 Nov; 47(23):5601-4. PubMed ID: 15509156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The graphical representation of ADME-related molecule properties for medicinal chemists.
    Ritchie TJ; Ertl P; Lewis R
    Drug Discov Today; 2011 Jan; 16(1-2):65-72. PubMed ID: 21074634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of known drug space. Natural products, their derivatives and synthetic drugs.
    Bade R; Chan HF; Reynisson J
    Eur J Med Chem; 2010 Dec; 45(12):5646-52. PubMed ID: 20888084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Known drug space as a metric in exploring the boundaries of drug-like chemical space.
    Mirza A; Desai R; Reynisson J
    Eur J Med Chem; 2009 Dec; 44(12):5006-11. PubMed ID: 19782440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates.
    Roughley SD; Jordan AM
    J Med Chem; 2011 May; 54(10):3451-79. PubMed ID: 21504168
    [No Abstract]   [Full Text] [Related]  

  • 10. In silico prediction of the solubility advantage for amorphous drugs - Are there property-based rules for drug discovery and early pharmaceutical development?
    Kuentz M; Imanidis G
    Eur J Pharm Sci; 2013 Feb; 48(3):554-62. PubMed ID: 23262058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A medicinal chemistry perspective on structure-based drug design and development.
    Maddaford SP
    Methods Mol Biol; 2012; 841():351-81. PubMed ID: 22222460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug- and lead-likeness, target class, and molecular diversity analysis of 7.9 million commercially available organic compounds provided by 29 suppliers.
    Chuprina A; Lukin O; Demoiseaux R; Buzko A; Shivanyuk A
    J Chem Inf Model; 2010 Apr; 50(4):470-9. PubMed ID: 20297844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramolecular hydrogen bonding in medicinal chemistry.
    Kuhn B; Mohr P; Stahl M
    J Med Chem; 2010 Mar; 53(6):2601-11. PubMed ID: 20175530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of MS/MS data. 1. A focus on pharmaceuticals containing carboxylic acids.
    Bandu ML; Watkins KR; Bretthauer ML; Moore CA; Desaire H
    Anal Chem; 2004 Mar; 76(6):1746-53. PubMed ID: 15018578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules?
    Hou T; Wang J; Zhang W; Xu X
    J Chem Inf Model; 2007; 47(2):460-3. PubMed ID: 17381169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The calculation of polar surface area from first principles: an application of quantum chemical topology to drug design.
    Bytheway I; Darley MG; Popelier PL
    ChemMedChem; 2008 Mar; 3(3):445-53. PubMed ID: 18161739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ask the experts: past, present and future of the rule of five.
    Baell J; Congreve M; Leeson P; Abad-Zapatero C
    Future Med Chem; 2013 May; 5(7):745-52. PubMed ID: 23651089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion.
    Wang J; Krudy G; Xie XQ; Wu C; Holland G
    J Chem Inf Model; 2006; 46(6):2674-83. PubMed ID: 17125207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pursuing the leadlikeness concept in pharmaceutical research.
    Hann MM; Oprea TI
    Curr Opin Chem Biol; 2004 Jun; 8(3):255-63. PubMed ID: 15183323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.